About
Technology
Issues
FAQ
Links
Official Page
Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.